Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
melinda 
09.11.21 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.70
09.11.21
€20.00
09.11.22
-62.04%
09.11.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
09.11.21 60%
sell
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
19.09.22 0%
buy
Transgene S.A.

Start price
Target price
Perf. (%)
€2.43
07.11.21
€2.80
07.11.22
-20.58%
08.11.22

Could be worthwhile Investment >10% per year
melinda 
07.11.21 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
melinda 
01.11.21 50%
sell
Sanofi S.A.

Start price
Target price
Perf. (%)
€78.83
23.09.22
€65.00
31.12.24
11.65%
01.11.22

Could be worthwhile Investment >10% per year
BiotechBee 
23.09.22 70%
sell
Sanofi S.A.

Start price
Target price
Perf. (%)
€78.83
23.09.22
€65.00
31.12.24
11.65%
01.11.22

Could be worthwhile Investment >10% per year
BiotechBee 
23.09.22 70%
sell
Sanofi S.A.

Start price
Target price
Perf. (%)
€78.83
23.09.22
€65.00
31.12.24
11.65%
01.11.22

Could be worthwhile Investment >10% per year
BiotechBee 
23.09.22 70%
sell
GSK plc

Start price
Target price
Perf. (%)
€15.10
23.09.22
€10.00
31.12.24
11.64%
01.11.22

Could be worthwhile Investment >10% per year
BiotechBee 
23.09.22 70%
sell
GSK plc

Start price
Target price
Perf. (%)
€15.10
23.09.22
€10.00
31.12.24
11.64%
01.11.22

Could be worthwhile Investment >10% per year
BiotechBee 
23.09.22 70%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€7.00
24.10.23
18.42%
29.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
24.10.22 60%
sell
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
18.10.22
-
18.10.23
0.78%
29.10.22

Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
me8 
18.10.22 0%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.54
15.10.22
€2.00
15.10.23
-0.88%
29.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
15.10.22 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
15.10.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
15.05.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
15.05.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
15.05.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
ngapali 
26.02.22 50%
sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
melinda 
26.10.21 50%
sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
melinda 
26.10.21 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.75
06.10.22
€0.000
06.10.23
-61.11%
24.10.22

Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.10.22 40%
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.68
27.06.22
-
27.06.23
-12.04%
23.10.22

Could be worthwhile Investment >10% per year
thomasw 
27.06.22 50%
sell
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
melinda 
07.11.21 50%
sell
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
melinda 
17.10.21 50%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment
Lokrim 
17.10.21 10%